- Home
- DBD vs ATRC Comparison
DBD vs ATRC Comparison
Compare DBD & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBD
- ATRC
- Stock Information
- Founded
- DBD 1859
- ATRC 2000
- Country
- DBD United States
- ATRC United States
- Employees
- DBD N/A
- ATRC N/A
- Industry
- DBD EDP Services
- ATRC Medical/Dental Instruments
- Sector
- DBD Technology
- ATRC Health Care
- Exchange
- DBD Nasdaq
- ATRC Nasdaq
- Market Cap
- DBD 1.9B
- ATRC 1.6B
- IPO Year
- DBD N/A
- ATRC 2005
- Fundamental
- Price
- DBD $60.05
- ATRC $35.31
- Analyst Decision
- DBD Strong Buy
- ATRC Strong Buy
- Analyst Count
- DBD 2
- ATRC 10
- Target Price
- DBD $75.00
- ATRC $49.60
- AVG Volume (30 Days)
- DBD 198.1K
- ATRC 712.5K
- Earning Date
- DBD 08-06-2025
- ATRC 07-29-2025
- Dividend Yield
- DBD N/A
- ATRC N/A
- EPS Growth
- DBD N/A
- ATRC N/A
- EPS
- DBD N/A
- ATRC N/A
- Revenue
- DBD $3,672,300,000.00
- ATRC $499,946,000.00
- Revenue This Year
- DBD $2.02
- ATRC $14.63
- Revenue Next Year
- DBD $1.96
- ATRC $12.62
- P/E Ratio
- DBD N/A
- ATRC N/A
- Revenue Growth
- DBD N/A
- ATRC 16.28
- 52 Week Low
- DBD $34.38
- ATRC $20.20
- 52 Week High
- DBD $61.01
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- DBD 63.94
- ATRC 58.24
- Support Level
- DBD $53.93
- ATRC $33.63
- Resistance Level
- DBD $60.57
- ATRC $37.80
- Average True Range (ATR)
- DBD 1.55
- ATRC 1.64
- MACD
- DBD 0.02
- ATRC 0.48
- Stochastic Oscillator
- DBD 86.39
- ATRC 68.47
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.